CSF p-tau Predicts Asymmetric Hippocampal Atrophy in Cognitively Unimpaired Older Adults

BackgroundHippocampal atrophy is a core marker of neurodegeneration in dementia, particularly in Alzheimers disease (AD). However, most studies focus on total hippocampal volume loss and overlook hemispheric asymmetry, which may reflect distinct biological processes. While tau pathology is closely linked to medial temporal lobe degeneration, it remains unclear whether tau is associated with asymmetric patterns of hippocampal atrophy. MethodsWe analyzed 483 cognitively unimpaired participants from the Alzheimers Disease Neuroimaging Initiative (ADNI) with baseline cerebrospinal fluid (CSF) phosphorylated tau (p-tau181) and amyloid-{beta} (A{beta}42) measurements and longitudinal structural MRI data over 10 years of follow-up. Total hippocampal volume and hemispheric asymmetry, defined as the absolute difference between left and right hippocampal volumes (|L-R|), were quantified at each visit. Linear mixed-effects models assessed associations between baseline CSF biomarkers and longitudinal changes in hippocampal asymmetry, adjusting for demographic factors, APOE {varepsilon}4 status, and baseline hippocampal volume. ResultsHigher baseline CSF p-tau181 was associated with greater increases in hippocampal asymmetry over time ({beta} = 1.20, SE = 0.43, p = 0.006). This association remained significant after additional adjustment for total hippocampal volume and baseline CSF A{beta}42. CSF total tau was highly correlated with p-tau181 (Spearmans {rho} =0.98, p < 0.001) and showed comparable associations with hippocampal measures. In contrast, baseline A{beta}42 was not associated with subsequent changes in hippocampal asymmetry. Both p-tau181 and A{beta}42 were associated with faster decline in total hippocampal volume. In amyloid-stratified analyses, p-tau181 was associated with increasing hippocampal asymmetry only among amyloid-negative individuals, whereas its association with total hippocampal atrophy was observed primarily in amyloid-positive individuals. ConclusionsCSF p-tau181 is associated not only with overall hippocampal atrophy but also with progressive hemispheric asymmetry, suggesting that tau-related neurodegeneration may manifest as both magnitude and imbalance of tissue loss. These findings support hippocampal asymmetry as a complementary neuroimaging marker that may capture non-amyloid-related medial temporal lobe degeneration in cognitively unimpaired older adults.